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Summary
 
With the aid of monoclonal antibody (mAb) 2625, raised against the lipopolysaccharide (LPS)
of 
 
Legionella pneumophila
 
 serogroup 1, subgroup OLDA, we isolated mutant 811 from the viru-
lent wild-type strain RC1. This mutant was not reactive with mAb 2625 and exhibited an un-
stable phenotype, since we observed an in vitro and in vivo switch of mutant 811 to the mAb
2625–positive phenotype, thus restoring the wild-type LPS. Bactericidal assays revealed that
mutant 811 was lysed by serum complement components, whereas the parental strain RC1 was
almost serum resistant. Moreover, mutant 811 was not able to replicate intracellularly in mac-
rophage-like cell line HL-60. In the guinea pig animal model, mutant 811 exhibited signifi-
cantly reduced ability to replicate. Among recovered bacteria, mAb 2625–positive revertants
were increased by fourfold. The relevance of LPS phase switch for pathogenesis of 
 
Legionella
 
infection was further corroborated by the observation that 5% of the bacteria recovered from
the lungs of guinea pigs infected with the wild-type strain RC1 were negative for mAb 2625
binding. These findings strongly indicate that under in vivo conditions switching between two
LPS phenotypes occurs and may promote adaptation and replication of 
 
L. pneumophila
 
. This is
the first description of phase-variable expression of 
 
Legionella
 
 LPS.
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L
 
egionella pneumophila
 
 is the causative agent of Legion-
naires’ disease, a severe pneumonia with frequently fatal
progression (1). The habitat of 
 
Legionella
 
 species are natural
or man-made water reservoirs where the bacteria survive
and multiply intracellularly in amebae (2–4) in tight associ-
ation with biofilms (5–7). Infection of man occurs by inha-
lation of 
 
Legionella
 
-containing aerosols, but person to per-
son transmission has never been observed (1, 8). In the
human lung attachment of 
 
L. pneumophila
 
 and internaliza-
tion into alveolar-macrophages is mediated by the major
outer membrane protein, MOMP,
 
1
 
 the complement fac-
tors C3b and iC3b and the corresponding receptors (9, 10).
In phagocytes fusion of 
 
Legionella
 
-containing phagosomes
with lysosomes is prevented and 
 
L. pneumophila
 
 survives
and multiplies within macrophages (11, 12).
Several virulence factors of 
 
L. pneumophila
 
 have been
identified and characterized. The macrophage infectivity
potentiator protein (Mip) plays an important role in infec-
tion of macrophages, although its precise function is un-
clear (13–20). The products of the 
 
icm
 
 and 
 
dot
 
 loci are re-
quired for intracellular multiplication. Again, their role in
the pathogenesis of disease is unresolved (21–25). Likewise,
LPS of 
 
L.
 
 
 
pneumophila
 
 is considered a factor mediating
pathogenicity (8). It is the major immunodominant antigen
and represents the basis for the classification of serogroups
(26–29). In contrast to enterobacterial LPS activation it has
been shown that 
 
Legionella
 
 LPS is able to activate both the
classical and the alternative complement pathway (30). Due
to the exceptional chemical structure of the 
 
L. pneumophila
 
LPS, it is likely that this molecule participates in a number
of essential legionellae capabilities, such as adaptation to
 
1
 
Abbreviations used in this paper:
 
 BYCE, buffered CYE; CI, chemical ion-
ization; CYE, charcoal yeast extract; EI, electron impact; GLC, gas–liquid
chromatography; MAC, membrane attack complex; MOMP, major outer
membrane protein; NHS, normal human serum; NMR, nuclear magnetic
resonance; SG, serogroup.
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Phase-variation of 
 
L. pneumophila
 
 LPS
 
various environmental challenges (31). The 
 
L. pneumophila
 
serogroup (SG) 1 (strain Philadelphia) LPS differs from that
of other Gram-negative bacteria in that its lipid A section
consists of long chain fatty acids which may account for the
weak endotoxicity of the molecule (31). The O-specific chain
is composed of an 
 
a
 
-(2
 
®
 
4) interlinked 5-acetamidino-7-acet-
amido-8-
 
O
 
-acetyl-3,5,7,9-tetradeoxy-
 
L
 
-
 
glycero
 
-
 
D
 
-
 
galacto
 
-non-
ulosonic acid (legionaminic acid) homopolymer. This un-
usual sugar molecule completely lacks free hydroxyl groups
and is thus very hydrophobic (31, 32). In addition, an iso-
mer of legionaminic acid hypothesized to be a terminal
sugar of the LPS O-chain has been recently detected (33).
The outer core oligosaccharide also exhibits hydrophobic
properties (34). Based on these findings, it can be assumed
that 
 
L. pneumophila
 
 possesses a hydrophobic cell surface that
may support concentration of the bacterium in aerosols as
well as adherence to host cells (31, 35).
To further elucidate the role of the LPS molecule and
the surface properties of 
 
L. pneumophila
 
 in adaptation to
various exogenous conditions, we raised mAb against the
LPS of 
 
L. pneumophila
 
 SG 1 (subgroup OLDA). In this
study, we describe mAb 2625 which binds to this LPS.
Moreover, we show that the O-chain as well as the core
are required for binding of mAb 2625. With the aid of
mAb 2625, we isolated an LPS mutant from the virulent
patient isolate RC1 (subgroup OLDA). Here we report for
the first time that the LPS structure appears to be a viru-
lence determinant of 
 
L. pneumophila
 
 and that expression of
 
L. pneumophila
 
 LPS occurs in a phase-variable manner.
 
Materials and Methods
 
Bacterial Strains and Cultivation. L.  pneumophila
 
 SG 1 strain
RC1 (OLDA), a clinical isolate, was a generous gift from B.
Wright (Rigshospitalet, Copenhagen, Denmark). All other 
 
Le-
gionella
 
 strains were obtained from the American Type Culture
Collection (Rockville, MD) and the National Collection of Type
Cultures (London, UK), respectively. Strains and sources are
listed in Table 1.
 
 Legionella
 
 strains were cultivated on charcoal
yeast extract (CYE) agar supplemented with buffered charcoal
yeast extract (BCYE) growth supplement and MWY selective
supplement (Unipath-Oxoid, Wesel, Germany). Plates were in-
cubated at 37
 
8
 
C under 5% CO
 
2
 
 for 48–72 h unless otherwise
stated. Propagation in liquid media (1% wt/vol yeast extract sup-
plemented with BCYE growth supplement) was carried out at
37
 
8
 
C under constant agitation.
 
Pseudomonas aeruginosa
 
 (ATCC 49266) was obtained from the
American Type Culture Collection. The following strains were
isolates from the Institut für Medizinische Mikrobiologie (Medi-
zinische Hochschule Hannover, Germany): 
 
P.
 
 
 
fluorescens
 
,
 
 Borde-
tella pertussis
 
,
 
 Acinetobacter lwoffii
 
, and 
 
Escherichia coli.
Production of Monoclonal Antibodies.
 
6-wk-old female BALB/c
mice (Zentralinstitut für Versuchstierkunde, Hannover, Germany)
were immunized intraperitoneally for four times once a week
with 2 
 
3
 
 10
 
8
 
 
 
L. pneumophila
 
 SG 1 strain RC1 viable cells as pre-
viously described (36). Before injection, bacteria were passaged
once in a guinea pig as described below. At the end of the immu-
nization regimen, mice were splenectomized and the spleen cells
were fused with X63-Ag8.653 myeloma cells as described else-
where (37). The culture supernatant fluids of growing clones
were screened by ELISA with whole 
 
L. pneumophila
 
 SG 1 (strain
RC1) cells as antigens. The resulting hybridomas were cloned by
limiting dilution.
 
Immunoelectron Microscopy.
 
Bacteria were fixed with 0.5%
formaldehyde and 0.2% glutaraldehyde (final concentrations) in
0.1 M PBS for 1 h on ice. After three washes with 0.1 M PBS
containing 10 mM glycine to block free aldehyde groups, the
cells were embedded by progressively lowering the temperature
with Lowicryl K4M resin (38). The following modifications of
the method were made: (
 
a
 
) after dehydration in 10% ethanol, the
samples were treated with 0.5% uranyl acetate in 10% ethanol for
1 h on ice; (
 
b
 
) the infiltration step with 1 part ethanol and 1 part
K4M resin was performed overnight; (
 
c
 
) the infiltration step with
one part ethanol and two parts K4M resin lasted for 12 h; and (
 
d
 
)
infiltration with pure K4M resin lasted for 2 d. After polymeriza-
tion of the samples for 2 d at 
 
2
 
35
 
8
 
C, samples were trimmed and
polymerized for another day at room temperature. Ultrathin sec-
tions were incubated overnight with 200 
 
m
 
g of IgG per ml of
mAb 2625 or mAb LPS-1 (39) at 4
 
8
 
C. mAb LPS-1 was purchased
from Progen (Heidelberg, Germany). After washing with 0.1 M
PBS, sections were incubated with protein A–gold complexes
(10-nm diam; concentration giving an A
 
520
 
 of 0.02). The sections
were subsequently rinsed with 0.1 M PBS containing 0.01%
Tween 20 and then with distilled water. After air drying, the sec-
tions were counterstained with 4% aqueous uranyl acetate (pH
4.5) for 5 min. Samples were examined with a Zeiss EM 910
electron microscope at an acceleration voltage of 80 kV at cali-
brated magnifications.
 
Western Blot.
 
1 ml of bacterial cell suspensions (OD
 
550nm
 
 1.2)
were centrifuged and the resulting pellet was resuspended in 100-
 
m
 
l
sample solution (20% glycerol, 3% sodium dodecyl sulfate, 3%
2-mercaptoethanol, 1% bromphenol blue). The suspensions were
heated to 100
 
8
 
C for 5 min before 5-
 
m
 
l aliquots were applied to
12.5% polyacrylamide gels. To ensure equal protein concentra-
tions in each lane, control gels were stained with Coomassie Blue
dye (Sigma Chemical Co., Deisenhofen, Germany). For analysis
of LPS samples, 2 
 
m
 
g purified LPS was applied to gels after boil-
ing in sample solution. Western blotting onto nitrocellulose filters
was carried out as described by Towbin et al. (40). Filter mem-
branes were blocked with 3% dried milk powder suspended in
PBS. Immunostaining was performed with mAb 2625 and mAb
LPS-1 (39), respectively, and subsequent incubation with alkaline
phosphatase-labeled goat anti–mouse immunoglobulin (Dianova,
Hamburg, Germany).
 
Colony Blot.
 
Nitrocellulose filters were soaked in sterile PBS
before colonies grown on BCYE agar were blotted. Filter mem-
branes were then placed for 5 minutes on paper filter sheets
(Schleicher and Schuell, Dassel, Germany) soaked with 70% etha-
nol. Nitrocellulose filters were air-dried at room temperature and
subsequently blocked with 3% dried milk powder suspended in
PBS. Immunostaining of the filters was performed as described
above.
 
Extraction of LPS and Isolation of O-Chain Polymers.
 
LPS of 
 
L.
pneumophila
 
 SG 1 strain RC1 (subtype OLDA) and mutant 811
was isolated from dry cells by a modified phenol-chloroform-
petroleum ether procedure as described (32, 41). Starting from
washed and enzymatically degraded dried cells excellent yields
were obtained ranging between 8.1% (wt/wt) for the wild-type
and 9.9% (wt/wt) for the mutant, respectively. LPS (155 mg of
the wild-type, 144 mg of the mutant) was degraded with 0.1 M
NaOAc-HOAc buffer (pH 4.4, 30 ml) at 100
 
8
 
C for 4 h and the
resulting precipitate was removed by centrifugation. The super-
natant was freeze-dried and fractionated by gel permeation chro- 
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matography on a Sephadex G-50 (S) column (2.5 
 
3
 
 50 cm; Phar-
macia Biotechnology Inc., Freiburg, Germany) using a pyridinium
acetate buffer (pH 4.5) and monitoring with a Knauer differential
refractometer. Appropriate fractions were pooled and lyophilized.
 
SDS-PAGE and LPS Silver Staining.
 
SDS-PAGE was carried out
in 14% polyacrylamide gels using Mini-Protean II system (Bio-
Rad Laboratories, München, Germany). LPS bands were visual-
ized by the silver-staining technique as described elsewhere (42).
 
Chemical LPS Analysis by Gas–Liquid Chromatography and Nuclear
Magnetic Resonance.
 
Gas–liquid chromatography (GLC) was per-
formed with a Varian Model 3700 chromatograph equipped with
a capillary column of SPB-5 using a temperature gradient
150
 
®
 
320
 
8
 
C at 5
 
8
 
C/min. GLC-mass spectrometry in both chem-
ical ionization (CI, with ammonia) and electron impact (EI)
modes was carried out with a Hewlett-Packard Model 5989 in-
strument equipped with a capillary column of HP-1 under the
same chromatographic conditions as in GLC. Monosaccharides
were analyzed by GLC after methanolysis with 2 M HCl/MeOH
(120
 
8
 
C, 16 h) and acetylation with Ac
 
2
 
O in pyridine (70
 
8
 
C, 0.5 h).
 
1
 
H- and 
 
13
 
C-nuclear magnetic resonance (NMR) spectra were
obtained with a Bruker AM-360 spectrometer for solutions in
D
 
2
 
O at 60
 
8
 
C with acetone (
 
d
 
H
 
 2.225, 
 
d
 
C
 
 31.45) as internal stan-
dard. Standard Bruker software was used in all 
 
1
 
H- and 
 
13
 
C-NMR
experiments.
 
Competition ELISA.
 
1 
 
m
 
g purified LPS from L. pneumophila
strain RC1 in 20 ml 0.2 M sodium carbonate buffer, pH 9.6, per
well was adsorbed to microtiter plates (Microlon, Greiner,
Nürtingen, Germany) overnight at 48C. Plates were subsequently
blocked with 2% (wt/vol) dried milk powder in PBS for 1 h at
room temperature. mAbs 2625 and LPS-1 (39), respectively,
were preincubated with carbohydrate fractions from wild-type
strain RC1 and mutant strain 811, respectively. These sugar frac-
tions containing O-chain polysaccharide with attached core oli-
gosaccharide were obtained from gel permeation chromatography
as described above. The polysaccharides were redissolved in dis-
tilled water to a concentration of 50 mg/ml. 1 ml of serial dilu-
tions of carbohydrate fractions was added to 19 ml dilutions of
mAb 2625 and mAb LPS-1, respectively. Before addition of the
sugars the antibodies were diluted to a suitable concentration in
PBS. In control reactions 1 ml distilled water was added to the an-
tibody dilutions instead of carbohydrate solutions. Coincubation
of mAbs and carbohydrate fractions was performed at 48C over-
night. After blocking and three washing steps with PBS, microti-
ter plates were incubated with the antibody–carbohydrate mix-
ture for 2 h at room temperature and subsequently washed with
PBS for three times. Detection was carried out by incubation of
the plates with peroxidase-labeled goat anti–mouse antibody (Di-
anova) for 1 h at room temperature. After three washing steps as
before the substrate H2O2 and azino-di-ethylbenzthiazolinsul-
fonate (ABTS) was added and after a 30-min incubation at room
temperature absorbance was determined in a microplate reader at
405 nm. Inhibition of antibody binding was calculated as percent-
age of the control reactions (no carbohydrates added). All reac-
tions were carried out in duplicates.
Bactericidal Assay. For investigation of serum resistance of L.
pneumophila wild-type strain RC1 and mutant strain 811 normal
human serum (NHS) was obtained from 10 healthy volunteers.
Blood was allowed to clot for 30 min at room temperature. After
centrifugation for 5 min at 2,000 g, the sera were pooled, quick-
frozen in liquid nitrogen and stored at 2808C. Pool serum was
negative for anti-L. pneumophila antibodies as determined by stan-
dard diagnostic serology methods (immune fluorescence test).
Bacteria were plated on BCYE agar from frozen stocks and sus-
pended in 0.9% saline after 40 h of incubation. Optical density
was determined at 600 nm and bacterial suspensions were appro-
priately diluted in 0.9% saline. 40% NHS was incubated with 106
bacteria in a final reaction volume of 1 ml. The reaction mixture
was incubated at 378C in a water bath and stopped on ice at 0, 15,
Table 1. Legionella Strains Used in this Study and Indication of the Source
Strain Source Strain Source
L. pneumophila SG 1 (OLDA) ATCC 43109 L. pneumophila SG 1 (Oxford) ATCC 43110
L. pneumophila SG 1 ATCC 33152 L. pneumophila SG 1 ATCC 33153
L. pneumophila SG 1 ATCC 43108 L. pneumophila SG 1 ATCC 43112
L. pneumophila SG 1 ATCC 43106 L. pneumophila SG 1 ATCC 43107
L. pneumophila SG 1 NCTC 11191 L. pneumophila SG 1 NCTC 11193
L. pneumophila SG 1 NCTC 11201 L. pneumophila SG 1 NCTC 11231
L. pneumophila SG 1 NCTC 11378 L. pneumophila SG 1 NCTC 11404
L. pneumophila SG 2 ATCC 33154 L. pneumophila SG 3 ATCC 33155
L. pneumophila SG 4 ATCC 33156 L. pneumophila SG 5 ATCC 33216
L. pneumophila SG 6 ATCC 33215 L. pneumophila SG 7 ATCC 33823
L. pneumophila SG 8 ATCC 35096 L. pneumophila SG 9 ATCC 35289
L. pneumophila SG 10 ATCC 43283 L. pneumophila SG 11 ATCC 43130
L. pneumophila SG 12 ATCC 43290 L. pneumophila SG 13 ATCC 43736
L. pneumophila SG 14 ATCC 43703 L. anisa ATCC 35291
L. cherrii ATCC 35252 L. erythra ATCC 35303
L. birminghamensis ATCC 43702 L. bozemanii ATCC 33217
L. dumoffii ATCC 33279 L. gormanii ATCC 33297
L. micdadei ATCC 3320452 Phase-variation of L. pneumophila LPS
30, and 60 min, respectively. Appropriate dilutions were plated
on BCYE agar.
Infection of HL-60 Cells with L. pneumophila. Infection of HL-60
cells was performed essentially as described (25, 43). Human mac-
rophage-like cell line HL-60 was propagated in RPMI 1640 me-
dium supplemented with 10% heat-inactivated fetal calf serum
(GIBCO BRL, Eggenstein, Germany). Differentiation of the cells
was induced with PMA (Sigma Chemical Co.) at a final concen-
tration of 1028 M. After 48 h of incubation with PMA cells were
washed and 0.5 3 106 adherent HL-60 cells per well were in-
fected with 104 bacteria of the appropriate L. pneumophila strain.
Bacteria were plated on BCYE agar from frozen stocks and har-
vested after 40 h incubation. The optical density of bacterial sus-
pensions in 0.9% saline was determined at 600 nm and appropri-
ate dilutions were prepared in RPMI medium. For determination
of intracellular multiplication, at 0, 24, 48, and 72 h after infec-
tion culture supernatants were removed, HL-60 cells were lysed
by suspending in ice-cold water. Suspended cells and supernatant
were pooled and aliquots of serial dilutions were plated on BCYE
agar.
In a second assay, extracellular remaining bacteria were killed
by adding gentamicin (GIBCO BRL) to a final concentration of
40 mg/ml after 2 h of coincubation of HL-60 cells and bacteria.
After a 2-h incubation time with gentamicin, cells were washed
again and incubated in antibiotic-free medium. Under these con-
ditions, HL-60 were infected with 106 bacteria per well. At time
intervals of 0, 24, 48, and 72 h after gentamicin removal, appro-
priate dilutions were plated for determination of intracellular
multiplication.
Intratracheal Infection of Guinea Pigs. Male and female guinea
pigs strain 2BS (400–600 g) obtained from the Zentrales Tierlab-
oratorium (Medizinische Hochschule Hannover, Germany) were
infected with L. pneumophila by intratracheal application of the
bacteria as described (15, 44). Animals were anesthetized by intra-
muscular injection of a mixture of 10 ml ketamine (10% solution)
and 10 ml xylazinhydrochloride (2% solution) per 100 g body
weight. Subsequently, a small skin incision was made in the ven-
tral neck and the bacterial suspension was injected into the ex-
posed trachea. Before inoculation, the appropriate L. pneumophila
strains were plated on BCYE agar from frozen stocks and were
incubated for 40 h. Bacteria were harvested and suspended in
0.9% saline to a concentration of 108/ml. 0.3 ml (corresponding
to 3 3 107 CFU) of this suspension was injected into the tracheal
lumen with a 24-gauge needle and the incision was closed with
sutures. In previous experiments, 3 3 107 CFU had been deter-
mined as the 50% lethal dose (LD50) of strain RC1 to guinea pig
strain 2BS within 3–5 d after infection. After the infection, ani-
mals were observed several times daily for signs of illness and re-
spiratory disease. 48 h after infection animals were killed and the
lungs were removed. Lung tissue was homogenized in 0.9% saline
and aliquots of serial dilutions of the lung suspensions were plated
on BCYE agar. For determination of recovered Legionella, CFU
were counted after 72 h incubation. Aliquots of the lung suspen-
sions were also plated on blood agar to control for contaminating
bacteria. Binding of injected and recovered bacteria to mAb 2625
was in all experiments monitored by colony blot assay. Animal
experiments were carried out with the permission and according
to the guidelines of local authorities.
Results
Characterization of mAb 2625. To generate mAbs, mice
were immunized with whole cells of L. pneumophila SG 1
strain RC1 (OLDA). Before the immunization, strain RC1
was subjected to a single guinea pig passage. Screening of
hybridoma supernatants in an ELISA with the same strain
used for immunization led to the isolation of IgG3 mAb
2625. The reactivity of mAb 2625 was not eliminated after
treatment with proteinase K, suggesting that a carbohydrate
epitope was recognized. Binding of mAb 2625 occurred
exclusively in strains belonging to the OLDA and Oxford
subgroups, of L. pneumophila SG 1, respectively, as deter-
mined by ELISA and Western blot analysis. There was no
binding reaction observed in any other of the 14 tested SG
1 strains. This was also the case for type strains from sero-
group 2 to 14. Likewise, eight non-pneumophila strains as
well as several bacteria from other genera were tested and
did not bind to mAb 2625. All of the investigated strains
are listed in Materials and Methods.
In electron microscopy experiments, the epitope on the
antigen bound by mAb 2625 could be localized to the cell
surface of L. pneumophila (Fig. 1). In Western blot analysis
of whole cell lysates and purified LPS, mAb 2625 exhibited
a ladder-like binding pattern characteristic of LPS (Fig. 2
A, lanes 1 and 3). With the aid of molecular mass standards
for SDS-PAGE, the ladder-like bands were estimated to be
in the range of 30–65 kD. This molecular mass range does
not correspond to the molecular mass of L. pneumophila
LPS, but permitted a relative comparison of LPS banding
patterns in Western blots. In control experiments, we incu-
bated Western blots with mAb LPS-1 (39), an mAb specific
to serogroup 1 of L. pneumophila. As shown in Fig. 2 B
(lanes 1 and 3), LPS-1 exhibited a ladder-like banding pat-
tern in the range of 20–30 kD and in addition, faint bands
in the range of 35–45 kD. This binding pattern corre-
sponds well to the image of L. pneumophila LPS bands
which become visible after silver staining (Fig. 3). From the
binding characteristics of mAb 2625, that is the banding
pattern in a higher molecular mass range than observed
with mAb LPS-1, we conclude that mAb 2625 binds a
conformational epitope, which is not generated before a
distinct O-chain length is achieved.
Isolation of LPS-Mutant Strain 811. Next, we wondered
whether mAb 2625–reactive epitope is present on all bac-
teria within a population. Therefore, we performed colony
blots on the virulent L. pneumophila strain RC1, a clinical
isolate of the OLDA subtype of serogroup 1, with mAb
2625. Using this strategy, we could show that mAb 2625–
negative colonies could be detected in a frequency of 1024.
We isolated one of the mAb 2625–negative colonies for
further analysis. Interestingly, the phenotype of this LPS
variant, termed 811, was unstable and exhibited a remark-
able switching back to the LPS phenotype of the parent
strain. This could be shown using mAb 2625. When a sin-
gle colony of the mutant 811 with mAb 2625 nonreactivity
confirmed by colony blot analysis was restreaked on BCYE
agar, 80–100% of the grown colonies were again positive
for binding of mAb 2625. Colony morphology of mutant
strain 811 did not exhibit any differences compared with
that of the wild-type strain, but the colony material ap-
peared extremely viscous and sticky. By repeating the pro-53 Lüneberg et al.
cedure of colony blots and restreaking single mAb 2625–
negative colonies (three passages), we could reduce the
proportion of mAb 2625–positive (wild-type) colonies of
the mutant 811 to z10%. For all experiments described in
the following paragraphs, the mutant 811 was subjected to
this treatment. The z10% portion of wild-type cells in the
mutant 811 population was controlled in all experiments
and confirmed by colony blot analysis with mAb 2625.
Mutant 811 replicated with the same growth rate in liquid
media as the wild-type RC1. As could be expected from
colony blot analysis, mutant 811 did not bind mAb 2625 in
Western blot analysis (Fig. 2 A, lanes 2 and 4). The faint
bands visible in lane 2 of Fig. 2 A are due to z10% wild-
type cells present in the bacterial suspension. In contrast,
mAb LPS-1 revealed enhanced binding to mutant 811 in
comparison to the parental wild-type strain RC1, resulting
in a more sensitive staining of high molecular mass LPS
populations. It is conceivable that LPS of mutant 811 is al-
tered in a way that the epitope bound by mAb LPS-1 be-
comes more accessible and antibody binding is thereby
promoted.
Chemical Analysis of the LPS O-Chain of OLDA Wild-type
RC1 and Mutant 811. To determine the chemical alter-
ation in LPS composition of mutant 811, which was indi-
cated by the antibody binding characteristics, we analyzed
the LPS O-chain as well as the core oligosaccharide of both
strains. For this purpose, the LPS from strains RC1 and
mutant 811 was isolated. In Western blot analysis, purified
LPS from both strains exhibited the same binding charac-
teristics with mAb 2625 and mAb LPS-1 as has been deter-
mined for cell lysates of the strains (Fig. 2, A and B, lanes 3
and 4). As recently published, the core oligosaccharide of
L. pneumophila SG 1 strain Philadelphia is composed of Rha/
QuiNAc/GlcNAC/Man/Kdo in a relative ratio of z2:1:2:
2:2 (34, 45). Analysis of the core sugar components of
strains RC1 and mutant 811 by GLC-MS revealed that
the same sugars were present in both strains. However,
complete analysis of the core structure has not yet been
accomplished. In particular, modification of sugars, confor-
mational structures, and ketosidic linkages within the core
remain to be established. Chemical analysis of the carbohy-
drate composition of the O-chain was performed by 1H- and
13C-NMR spectra analysis. It was found that the O-specific
chain was composed of a homopolymer of a-(2®4) in-
terlinked 5-acetamidino-7-acetamido-3,5,7,9-tetradeoxy-
L-glycero-D-galacto-nonulosonic acid (8-de-O-acyl derivative
of legionaminic acid). No structural difference was observed
between the 8-O-deacetylated legionaminic acid in the
two strains investigated. In addition, length distribution of
the LPS O-chain was identical in wild-type RC1 and mu-
tant 811, as was determined by SDS-PAGE and gel perme-
ation chromatography. SDS-PAGE of purified LPS from
RC1 and 811 revealed a ladder-like banding pattern with a
bimodular distribution of O-chain length which is typical
for Legionella LPS (Fig. 3). No difference in banding pattern
was observed between wild-type and mutant. Moreover,
both strains exhibited a banding pattern very similar to that
of L. pneumophila SG 1 strain Philadelphia. In conclusion,
no difference in O-chain structure and length was observed
between wild-type RC1 and mutant 811, further confirm-
ing chemical data indicating the O-chain not to be changed
in the mutant.
Epitope Mapping of mAb 2625 and mAb LPS-1. To de-
termine the region of the LPS molecule where a structural
difference between wild-type RC1 and mutant 811 could
be located, we attempted to map the epitopes bound by
mAb 2625 and mAb LPS-1, respectively. For this purpose
we investigated the binding capacity of sugar fractions ob-
tained from the gel filtration assay. Before separation on
Sephadex columns, the lipid A moiety had been removed
from LPS by mild acid hydrolysis. After gel filtration three
Figure 1. Immunoelectron microscopy of L. pneumophila SG 1 strain
RC1 (OLDA). Staining of sections was performed with mAb 2625 (a). In
control experiments sections were immunostained with mAb LPS-1 (39),
which binds specifically to LPS of L. pneumophila SG 1 (b). G, gold-parti-
cle. Bar, 0.25 mm.
Figure 2. Western blot analysis of wild-type strain RC1 and mutant
811 with mAb 2625 (A) and mAb LPS-1 (B), respectively. Lane 1, wild-
type RC1 whole cell lysate; lane 2, mutant 811 whole cell lysate; lane 3,
wild-type RC1 2 mg purified LPS; lane 4, mutant 811 2 mg purified LPS.
Numbers on the left side indicate molecular masses of a standard protein
marker. The molecular mass of L. pneumophila LPS does not correspond
to that of the marker proteins, but determination of a relative range of
LPS bands was achieved by this method.54 Phase-variation of L. pneumophila LPS
fractions of O-chain with attached core oligosaccharide
were eluted from the column: fraction I represented the
long O-chain (45-100-mer); fraction II the short O-chain
(10-35-mer); and fraction III the isolated core oligosaccha-
ride. The LPS bands separated by SDS-PAGE, which cor-
respond to fractions I and II, are indicated in Fig. 3. All
fractions eluted from the column contained the carbohy-
drate moiety of LPS (O-specific chain attached to the core)
alone and therefore could not be analyzed by Western blot
or conventional ELISA techniques. For this reason we per-
formed a competition ELISA which is based on the princi-
ple of inhibition of antibody binding to LPS by LPS carbo-
hydrate fractions. Purified LPS from L. pneumophila SG 1
wild-type RC1 was adsorbed to microtiter plates. mAb
2625 and LPS-1, respectively, were preincubated with se-
rial dilutions of sugar fractions obtained from Sephadex gel
filtration. In this way we investigated fractions I and II
from wild-type RC1 and mutant 811 as well as the core
portion of both strains. The results of the competition
ELISA are illustrated in Fig. 4. Binding of mAb 2625 is in-
hibited in a concentration dependent manner by carbohy-
drates from fractions I and II of wild-type RC1, but not by
the core oligosaccharide, indicating that the epitope bound
by mAb 2625 involves the O-specific chain. It is notewor-
thy, that carbohydrates from fraction II exhibited a de-
creased binding to mAb 2625 in comparison to those from
fraction I. O-chain molecules of the required length are
presumably only present as a minor part of fraction I. For
mutant 811, weak binding of carbohydrates from fraction I
to mAb 2625 is due to wild-type bacteria (z10%, see
above) that are inherent to the unstable character of 811.
Inhibition of binding of mAb LPS-1 occurred in a likewise
dose-dependent way. Carbohydrates from fractions I and
II, as well as the core fractions from wild-type RC1 and
mutant 811, were bound by mAb LPS-1. As already shown
in Western blot analysis (see Fig. 2), binding of mAb LPS-1
to 811 is increased in comparison to wild-type RC1 (Fig. 4,
C and D). In conclusion, mAb 2625 binds the LPS O-chain,
but not the isolated core oligosaccharide. However, we
cannot exclude that the core moiety is also required for
mAb 2625 binding, since carbohydrates from fractions I
and II contain the core portion as well as the O-chain.
Since no differences in the O-antigen composition by
chemical analysis could be observed, we conclude that the
epitope bound by mAb 2625 is a conformational epitope
which involves both the O-chain and the core. In contrast,
the epitope bound by mAb LPS-1 is clearly located in the
core oligosaccharide, and the O-chain is not required for
binding. Together with the results obtained from chemical
analysis, these data strongly support the idea, that alterations
in the core oligosaccharide of mutant 811 are responsible
for loss of mAb 2625 binding and increased binding to
mAb LPS-1.
Intracellular Replication of RC1 and 811 in HL-60 Cells.
Virulence of mutant 811 in comparison to the parent strain
RC1 was determined by infection of human macrophage-
like cell line HL-60 and determination of CFU on days 1
to 3 after infection. 2 3 106 HL-60 cells were infected with
104 bacteria from frozen stocks. Wild-type strain RC1
proved to be virulent and replicated in HL-60 cells by 2
orders of magnitude within 72 h (Fig. 5). A mAb 2625–
positive revertant of mutant 811 (811-rev.) served as a con-
trol in these experiments. It is well known that virulence of
pathogenic bacteria is attenuated or even abolished after
laboratory passage on artificial media, strain 811-rev. was
therefore employed to identify those effects due to agar
passage. In comparison with the animal passaged wild-type
strain RC1, 811-rev. exhibited a slightly reduced growth
rate, but proved to be virulent (Fig. 5). In contrast, mutant
811 failed to replicate intracellularly in HL-60 cells. The
number of recovered bacteria at all time intervals remained
in the range of the inoculum (Fig. 5). In conclusion, wild-
type RC1 proved to be able to replicate in HL-60 cells,
whereas mutant 811 showed no replication and conse-
quently proved to be avirulent. Moreover, by investigating
811-rev., it became evident that switching of 811 to the
wild-type LPS-phenotype (mAb 2625 binding) also re-
stored virulence. These findings indicate that alteration of
LPS carbohydrate moiety was the only mutation that had
occurred in 811. When gentamicin was added to kill extra-
cellular bacteria after 2 h of coincubation of host cells and
bacteria, mutant 811 was found intracellularly to approxi-
mately the same extent as wild-type RC1 and 811-rev.
(Fig. 6). These data show that mutant 811 entered HL-60
cells as efficiently as the wild-type strain, but was unable to
replicate in the host cell. Colony blot analysis of mutant
811 revealed that the percentage of mAb 2625-positive re-
vertants among bacteria recovered from the HL-60 infec-
tion assays was identical to that of the inoculum.
Investigation of Serum Resistance. To determine the bac-
tericidal activity of complement present in NHS on wild-
type RC1, mutant 811 and 811-rev., we performed bacte-
ricidal assays as described in Materials and Methods. After a
1-h incubation in 40% serum, number of bacteria from
wild-type strain RC1 declined by ,1 log. Thus, wild-type
RC1 was not completely, but almost serum resistant. In
contrast, the number of viable bacteria from mutant 811
declined by 3 logs (from 6.1 log10 to 3.2 log10) within 15
min incubation in 40% NHS (Fig. 7). After 30 min no via-
ble bacteria were recovered (detection limit 102 CFU/ml).
Therefore, mutant 811 was serum-sensitive and the sensi-
Figure 3. SDS-PAGE and sil-
ver staining of LPS from L. pneu-
mophila SG 1. 2 mg purified LPS
were applied to each lane. Lane
1, mutant 811; lane 2, wild-type
RC1; lane 3, strain Philadelphia.
All strains exhibit a characteristic
bimodular distribution of LPS
O-chain representing 10–35 and
45–100 carbohydrate units, re-
spectively. On the left side, LPS
bands corresponding to fractions
I and II of the gel filtration on Sephadex columns are indicated. These
fractions were employed for epitope mapping by competition ELISA. As
a control, 2 mg purified LPS from P. aeruginosa subgroup Fisher 2 was ap-
plied to lane 4.55 Lüneberg et al.
tivity is related to an altered LPS conformation. Incubation
of 811-rev. in 40% NHS revealed that the number of via-
ble bacteria was reduced by 2 logs within 1 h (Fig. 7).
These findings indicate that agar passage does indeed have
an influence on serum resistance, even though its effect is
minor. From the results of the bactericidal assays, we con-
clude that the alteration in LPS carbohydrate moiety of
mutant 811, which is presumably located in the core oli-
gosaccharide, results in deprivation of resistance against se-
rum complement activity. In addition, our data show that
serum resistance of L. pneumophila is mediated by the LPS
carbohydrate moiety.
In Vivo Virulence of Wild-type RC1 and Mutant 811.
Next, we were interested to study virulence of mutant 811
under in vivo conditions in the guinea pig animal model.
Animals (n 5 4 for each bacterial strain) were infected by
intratracheal injection of bacteria. On day 2 after infection,
animals infected with the wild-type strain RC1 exhibited
signs of severe illness as fever, ruffled fur, almost no motion
and reaction and respiratory distress. Animals were killed
on day 2 after infection and lungs were removed. The
lungs appeared greatly enlarged and were completely hem-
orrhagic. After homogenization of the lungs, aliquots of the
homogenates were plated for determination of the number
of bacteria. 6.5 3 109 (mean value) bacteria were recovered
from the animals (Fig. 8). The control blood agar plates
were found to be sterile. In contrast, the animals infected
with the mutant strain 811 showed moderate signs of ill-
ness, such as elevated body temperature and limited mo-
tion, but did not show signs of respiratory distress. These
animals were also killed on day 2 after infection. Lungs
were only slightly enlarged and hemorrhagic patches were
visible, but were not distributed over the entire lung tissue.
1.8  3 108 viable bacteria (mean value) were recovered
from the animals, a significantly lower number than was
determined for the wild-type strain (Fig. 8). Interestingly,
colony blot analysis of strain 811 isolated from animal lungs
revealed that 35% of the recovered bacteria were positive
for mAb 2625 binding, whereas only 8% of the inoculated
bacteria were mAb 2625-positive. These results indicate that
under in vivo selective pressure the 2625–positive phenotype
(wild-type phenotype) is evidently advantageous over the
Figure 4. Epitope mapping of mAb 2625 (A and B) and mAb LPS-1 (C and D), respectively. Inhibition of binding of mAb 2625 and mAb LPS-1 to
LPS from wild-type RC1 by LPS fractions from wild-type RC1 (A and C) and mutant 811 (B and D) was analyzed by competition ELISA. Percentage
of inhibition is given as means of duplicate values. Fraction I is represented by circles, fraction II by squares and the core portion by triangles.56 Phase-variation of L. pneumophila LPS
mAb 2625–negative phenotype of mutant 811. It remains
unclear if a preferential replication of the mAb 2625–posi-
tive portion of mutant 811 occurred or if switching back to
the wild-type phenotype is promoted under in vivo condi-
tions.
On the other hand, for the wild-type strain RC1 we ob-
served a significantly increased switching frequency under
in vivo conditions to the mAb 2625–negative phenotype.
A frequency of 5 3 1022 among recovered bacteria from
guinea pig lungs was determined by colony blot assay,
whereas mAb 2625–negative clones could be detected
among agar plated bacteria in a frequency of only 1024 (see
above).
In conclusion, mutant 811 was not able to cause severe
pneumonia as the wild-type RC1 did in the animal host
and showed a significantly reduced replication in compari-
son to the wild-type strain. Even though mutant 811 was
completely serum sensitive, it was not cleared from the an-
imal lung. Moreover, our data strongly indicate that two
LPS phases of L. pneumophila are expressed in vivo.
Discussion
We here describe the isolation and investigation of an
LPS-mutant of Legionella pneumophila SG 1, subgroup
OLDA. In comparison to other Gram-negative bacteria, L.
pneumophila exhibits an unusual LPS structure (31, 32, 34).
The chemical structure has recently been analyzed for L.
pneumophila SG 1, subgroup Philadelphia. It was found that
the lipid A moiety consists of long-chain fatty acids which
may account for its low endotoxic activity (31). The core
oligosaccharide lacks heptose and phosphate groups and ex-
hibits hydrophobic properties due to the presence of four
O-acetyl groups and three deoxy-sugars (Rha 2, QuiNAc)
(31, 34), which has so far not been found in any other bac-
Figure 5. Infection of HL-60 cells with L. pneumophila strains RC1 (cir-
cles), 811 (triangles), and 811-rev. (squares). CFU were determined at 24,
48, and 72 h post infection and are shown as means of duplicates.
Figure 6. Infection of HL-60 cells with L. pneumophila. After 2 h coin-
cubation of host cells and bacteria, extracellularly remaining bacteria were
killed by gentamicin. The CFU determined at day 0 therefore represent
intracellular bacteria. (Circles) Wild-type RC1; (triangles) mutant 811;
(squares) 811-rev. CFU are shown as mean of duplicates.
Figure 7. Bactericidal assay for determination of the lytic effects of se-
rum complement on wild-type RC1 (circles), mutant 811 (triangles) and
811-rev. (squares). Bacteria were incubated with 40% normal human se-
rum at 378C. Aliquots of the reactions were plated at different time inter-
vals for determination of viable bacteria. CFU are shown as mean of du-
plicates.
Figure 8. Investigation of virulence of L. pneumophila wild-type strain
RC1 (circle) and mutant 811 (triangle) in the guinea pig animal model. An-
imals were intratracheally infected with 3 3 107 bacteria. Number of re-
covered bacteria was determined 48 h after infection by plating aliquots of
lung suspensions.57 Lüneberg et al.
terial strain. The O-chain is composed of an unbranched
homopolymer with a-(2®4) interlinked 5-acetamidino-
7-acetamido-8-O-acetyl-3,5,7,9-tetradeoxy-L-glycero-D-galacto-
nonulosonic acid, termed legionaminic acid. Due to the
lack of free hydroxyl groups and characteristic substituents,
the O-chain is highly hydrophobic (31, 32). In this study
we determined the chemical structure of the LPS O-anti-
gen of L. pneumophila SG 1, subgroup OLDA. The O-chain
was found to be of the same structure as the one from Phil-
adelphia (31, 32), except that it lacks the 8-O-acetyl group
and therefore is termed 8-O-deacetyl-legionaminic acid.
The finding that OLDA strains all lack the 8-O-acetyl
group was expected after the serological data gained by in-
vestigating antibody reactivities: the 8-O-acetyl group is
known to be involved in binding of mAb 2 (27) and mAb
3/1 (46). In contrast, both antibodies do not bind to strains
of the subgroup OLDA. The length of the O-chain of sub-
group OLDA shows a bimodal distribution with maxima at
10–35 and 45–100 carbohydrate units, respectively. This
banding pattern is very similar to that obtained for sub-
group Philadelphia (32). LPS-mutant 811 did not show any
differences in O-chain structure and length when com-
pared with its parent wild-type strain RC1. Therefore, we
conclude that LPS of mutant 811 is altered in the core oli-
gosaccharide.
Mild acid hydrolysis in acetate buffer was used to cleave
the lipid A moiety from the carbohydrate moiety of the
LPS molecule. Under these conditions the ketosidic link-
ages of Kdo and iso-legionaminic acid are as well cleaved
(32–34, 45), whereas O-acetyl groups remain intact (34,
45). It can be excluded that artifacts created by the acid hy-
drolysis treatment prevented the identification of modifica-
tions of the mutant 811 LPS compared with the wild-type
LPS. Epitope mapping experiments showed that carbohy-
drate fractions isolated after mild acid hydrolysis and gel
permeation chromatography still were able to compete for
epitope binding by mAbs 2625 and LPS-1. If artifacts were
generated by the degradation procedure, they did not in-
terfere with those substituents important for formation of
the epitopes bound by mAbs 2625 and LPS-1.
Our idea that the core sugar composition of mutant 811
differs from that of the parent wild-type RC1 is supported
by the results of epitope mapping of mAb 2625 and mAb
LPS-1. With the aid of a competition ELISA method we
could show that mAb LPS-1 binds to the core oligosaccha-
ride of L. pneumophila SG 1. mAb LPS-1 shows a stronger
binding to mutant 811 than to wild-type RC1, indicating
that alterations in the core structure of 811 enhance the ac-
cessibility of the LPS-1 epitope. In contrast, mAb 2625
binds to the LPS O-chain and the core oligosaccharide is
presumably also involved in formation of the epitope.
Moreover, short-chain polysaccharides showed a reduced
binding to mAb 2625 in comparison to long-chain frac-
tions. This finding supports our hypothesis that a distinct
O-chain length is required for mAb 2625 reactivity.
In vitro and in vivo experiments revealed that virulence
of mutant 811 was significantly reduced in comparison to
the wild-type strain RC1. In in vitro assays, LPS-mutant
811 was unable to replicate intracellularly in macrophage-
like cells even though the mutant bacteria were able to en-
ter the host cells. In addition, mutant 811 was rapidly killed
by serum complement factors, whereas the corresponding
wild-type strain was almost resistant to complement lysis.
By comparative analysis of LPS-mutant 811 and the parent
wild-type RC1, these data show for the first time that resis-
tance to serum complement of L. pneumophila is mediated
by LPS carbohydrate moiety. However, we cannot exclude
that the LPS variation of mutant 811 leads to additional
modifications in the formation of the outer membrane.
Such alterations could for example affect surface molecules
which might as well be required for serum resistance and
virulence of L. pneumophila. For many bacterial pathogens,
surface polysaccharide structures such as capsules and LPS
were found to be involved in complement inhibition (re-
viewed in references 47, 48). Currently we do not know
whether killing of mutant 811 by serum complement fac-
tors is due to an increase in insertion of membrane attack
complex (MAC) into the membrane of mutant 811 or if
insertion of MAC occurs to the same extent in both, wild-
type and mutant, but does not lyse wild-type cells. There-
fore, future experiments should address the ability of wild-
type RC1 and mutant 811 to prevent or promote insertion
of MAC. In particular, activation of complement and depo-
sition of complement factors C3b and C3bi on the cell sur-
face is of special interest, since these molecules are known
to mediate uptake into the host cells via complement re-
ceptors CR1 and CR3 (9, 10).
In the guinea pig animal model, mutant 811 was not able
to cause severe pneumonia in guinea pigs infected with a
dose that corresponds to the LD50 of wild-type strain RC1.
Moreover, number of wild-type bacteria recovered from
the lungs of infected animals exceeded the number of mu-
tant bacteria recovered from infected animals by 1 to 2 or-
ders of magnitude. Most interestingly, LPS-mutant 811 ex-
hibited an unstable phenotype. The majority of cells from
the originally isolated clone 811, which was negative for
mAb 2625 binding, switched back to the wild-type pheno-
type and restored mAb 2625 binding. This phase variation
between two LPS phenotypes was found to be immensely
promoted in vivo in the animal host. Inoculated bacteria of
mutant 811 included 8% cells positive for mAb 2625 bind-
ing of the wild-type phenotype. In contrast, among recov-
ered bacteria from the infected animals the portion of wild-
type bacteria was increased to 35%, indicating a selective
advantage of the wild-type phenotype over the mutant
phenotype. Bacteria recovered from animals infected with
the wild-type RC1 contained 5% cells negative for mAb
2625 binding and therefore exhibiting the phenotype of
mutant 811. We observed the same phase variation of
wild-type RC1 and mutant 811 when the bacteria were in-
cubated with heat inactivated human serum for 1 h (data
not shown). Our results strongly indicate that phase varia-
tion of L. pneumophila LPS is induced and promoted by the
animal host and by human serum. This is the first descrip-
tion of a phase-variable expression of surface polysaccha-
rides of L. pneumophila. Diversity of surface carbohydrates58 Phase-variation of L. pneumophila LPS
achieved by means of high-frequency, reversible switching
of sugar epitopes has been described and intensively studied
in Haemophilus influenzae (49–58), Neisseria gonorrhoeae (59,
60) and N. meningitidis (61–64). In H. influenzae, expression
of enzymes involved in LPS biosynthesis is controlled by
multiple repeats of tetrameric nucleotides within the lic,
lex2, and lgtC loci (50, 56, 58). A change in the number of
tetrameric repeats, arising through slipped-strand mispair-
ing, results in a frame shift mutation, thus preventing ex-
pression of the encoded enzyme. Generation of phenotypic
LPS variation by these intragenic alterations is considered as
a virulence mechanism, enabling the bacteria to adapt to
different environmental conditions (55). Essentially the
same slipped-strand mispairing mechanism is found in Neis-
seria. Genes of the lgt locus, encoding glycosyl-transferases
responsible for LPS biosynthesis, are expressed or not de-
pending on the number of guanosine residues within a
poly-G stretch in the coding sequence (59–61). In N. men-
ingitidis, expression of the terminal lacto-N-neotetraose on
the LPS, which requires the glycosyl-transferase encoded
by lgtA, is correlated with serum resistance, non-invasive-
ness and predominance in the blood of infected mice. In
contrast, strains with the lacto-N-neotetraose negative LPS
phenotype are serum-sensitive, invasive and predominantly
found in the nasopharynx (61, 62, 65, 66). For L. pneumo-
phila, it remains to be established by which molecular
mechanism LPS phase variation is determined. A prerequi-
site to further investigate this question is the characteriza-
tion of genes involved in LPS biosynthesis. Except for an
O-acetyl-transferase gene (Mintz, C.S., unpublished data,
accession number U32118) such genes have not yet been
identified in Legionella.
Species of the genus Legionella do not express a capsule
or an exopolysaccharide. Therefore the LPS carbohydrate
moiety is the predominant molecule on the cell surface of
these bacteria which contributes to the cell surface proper-
ties in an exceptionally important way. Nothing is known
about adherence of legionellae to the lung epithelium. The
ability of L. pneumophila to replicate in alveolar epithelial
cells has been reported (67, 68). It is conceivable that adhe-
sion and tight attachment to epithelial cells is a crucial step
in infection before the target host cell can be invaded. At-
tachment and adhesion could be mediated by surface car-
bohydrates such as LPS, which has been suggested to act as
an adhesin of numerous pathogenic bacteria (reviewed in
reference 69). Moreover, LPS of L. pneumophila may also
be involved in attachment to its host cell. In a very recent
study, a 170-kD lectin of Hartmanella vermiformis has been
identified as a potential receptor used by L. pneumophila to
invade the protozoan cell (70). However, the ligand on the
bacterial surface remains to be identified. Future studies
should therefore focus on the role of LPS in attachment
and adhesion to different host cells and environments that
are exploited by L. pneumophila.
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